Telomir Pharmaceuticals, Inc.

8-K Regulation FD disclosure Jun 15, 2026 8-K Director or officer change Jun 8, 2026 8-K Regulation FD disclosure May 20, 2026 10-Q Quarter ended 2026-03-31 May 14, 2026 8-K Other events Apr 30, 2026 8-K Entered a material agreement; Completed an acquisition or disposition; Unregistered sale of equity Apr 24, 2026 8-K Other events Mar 31, 2026 8-K Other events Mar 31, 2026 8-K Director or officer change; Amended charter or bylaws; Shareholder vote results Mar 27, 2026 10-K Fiscal year ended 2025-12-31 Mar 17, 2026 8-K Other events Feb 17, 2026 8-K Other events Feb 5, 2026 8-K Delisting notice or listing-rule failure Jan 12, 2026 8-K Other events Jan 5, 2026 8-K Director or officer change Dec 22, 2025 8-K Other events Dec 17, 2025 8-K Other events Nov 24, 2025 8-K Director or officer change Nov 20, 2025 8-K Other events Nov 20, 2025 8-K Other events Nov 12, 2025 10-Q Quarter ended 2025-09-30 Nov 10, 2025 8-K Other events Oct 22, 2025 8-K Entered a material agreement Oct 20, 2025 8-K Other events Oct 14, 2025 8-K Other events Oct 8, 2025 8-K Other events Oct 6, 2025 8-K Other events Sep 18, 2025 8-K Other events Sep 9, 2025 8-K Other events Sep 4, 2025 8-K Other events Aug 27, 2025 10-Q Quarter ended 2025-06-30 Aug 14, 2025 8-K Other events Aug 7, 2025 8-K Other events Jul 23, 2025 8-K Other events Jul 22, 2025 8-K Other events Jul 17, 2025 8-K Other events Jun 18, 2025 8-K Other events Jun 11, 2025 8-K Other events Jun 5, 2025 8-K Other events Jun 2, 2025 8-K Other events May 29, 2025